Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Eur Respir Rev · 2022 · PMC9724805 · PMID 36198418

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Six months of riociguat treatment was associated with a significant increase of RV SVI and a nonsignificant trend of RV ejection fraction improvement compared with baseline.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.